May 10
|
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
|
May 10
|
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
|
May 10
|
Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
|
May 10
|
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
|
May 10
|
Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
|
May 10
|
US STOCKS-Wall St gains ahead of Fed officials' remarks; Dow nears 40,000 mark
|
May 10
|
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
|
May 9
|
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts
|
May 7
|
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
May 7
|
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024
|
May 6
|
UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
|
May 6
|
Shah Capital urges Novavax shareholders to vote against three directors
|
May 6
|
CORRECTED-UPDATE 3-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
|
May 6
|
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
|
Apr 30
|
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
|
Apr 29
|
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
|
Apr 25
|
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
|
Apr 22
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
Apr 21
|
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
|
Apr 19
|
12 Most Shorted Stocks in 2024
|